Shockwave Medical Inc (NASDAQ:SWAV) is in the spotlight today, after blue-chip pharmaceutical giant Johnson & Johnson (JNJ) announced it would buy the company for $12.5 billion, boosting its portfolio of cardiovascular disease treatment devices. SWAV was last seen up 1.8% at $325.77 after the news, while JNJ is down 0.07% at $152.38.SWAV received a pair of bear notes in response. Needham downgraded the stock to "hold" from "buy," while Piper Sandler slashed its rating to "neutral" from "overweight." Of the ...

ToplineJohnson & Johnson will acquire Shockwave Medical in a deal valued at $13.1 billion, according to a joint statement Friday, the latest acquisition by the pharmaceutical firm over the last two years as it expands on cardiovascular intervention.The pharmaceutical firm said the acquisition will boost its portfolio for treating two common forms ... [+] of heart disease.Getty Images Key FactsJohnson & Johnson will pay $335 per share in cash for Shockwave, the manufacturer of a catheter-based treatment for ...

Johnson & Johnson (NYSE:JNJ) is buying medical device company Shockwave Medical (NASDAQ:SWAV) for $13.1 billion. Shockwave makes devices that perform Intravascular Lithotripsy. They break up calcium deposits in arteries with sound waves, in the same way kidney stones have been treated for 30 years. The announcement had limited impact on the stock, however. SWAV stock was set to open this morning at about $325 per share, up just 1.6% from its April 4 close. JNJ stock was nearly unchanged at $153.Why No Big S ...

Dow Jones giant Johnson & Johnson (JNJ) said it would acquire Shockwave Medical (SWAV) for $13.1 billion, or $335 a share. Both stocks rose slightly early Friday.X Shockwave rose 1.6% to about 325. J&J edged higher.SWAV stock had surged 68% to 319.99 as of April 4 in 2024, with takeover speculation among the driving forces. JNJ stock had fallen 2.7%.Shockwave Medical is a leader in intravascular lithotripsy, a method of cracking hardened calcium in blood vessel walls.J&J said the deal will boost its positio ...

Shockwave Medical Inc (NASDAQ: SWAV) is in the green today after Johnson & Johnson (NYSE: JNJ) said it will buy the medical device maker for $12.5 billion.Shockwave Medical stock priced at a premium Copy link to section The all-cash agreement values each share of Shockwave Medical at $335 – a 5.0% premium on their previous close. JNJ expects the acquisition to help it further expand its footprint in cardiovascular interventions. Joaquin Duato – its chief executive said in a press release today:Shockwave and ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Johnson & Johnson (JNJ) , which belongs to the Zacks Large Cap Pharmaceuticals industry, could be a great candidate to consider.When looking at the last two reports, this world's biggest maker of health care products has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 3.22%, on average, in the last two qua ...

Ivory Soap is one of the brands for which Procter & Gamble is known. The company will extend its dividend growth streak to 69 years in April. NNehring This is the latest in my series of articles where I provide predictions of annual dividend increases for long-term dividend growth companies. In the middle of February, I provided predictions for 11 dividend growth companies that have historically announced annual payout increases in March. In this article I'll look at another 10 dividend growth companies tha ...

Johnson & Johnson (JNJ) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.Shares of this world's biggest maker of health care products have returned -2% over the past month versus the Zacks S&P 500 composite's +3.7% change. The Zacks Large Cap Pharmaceuticals industry, to which Johnson & Johnson belongs, has gained 2% over this period. Now the key question is: Where could the stoc ...

Dividend investing is one of the prominent ways to build wealth. Whether you are building a retirement portfolio, want to leave a legacy, or are looking to use the dividend income to cover your expenses, the right dividend stocks can make it possible. However, not all dividend stocks are the same. They can provide regular income but you need to ensure this income is consistent. This is why it makes sense to invest in companies that have a record of paying steady dividends. Consistency and stability are the ...

Johnson & Johnson’s (JNJ) wholly-owned subsidiary, Johnson & Johnson MedTech, recently announced its partnership with Nvidia to accelerate secure, real-time analysis of surgical data using artificial intelligence (AI).The two businesses collaborated to enable more global availability of AI algorithms and real-time analytical access. Their goal is to have an impact on surgical decision-making, teamwork, and education in all linked operating rooms (ORs).Price PerformanceFor the past six months, JNJ’s shares h ...